BNN provides English-language US and world news, analysis and opinion from all over the Internet. We strive for high standards, ethical behavior, and the presentation of multiple responsible points of view.
|
Get More Traffic For Your Blog! Blog Explosion brings hundreds of interested visitors to your blog - without costing you a cent. BNN News Archive Page |
Saturday, September 23, 2006
New Generic drugs for treating HIV patients in India Gilead life sciences, in a move to soften controversies for not doing anything to help people infected with HIV in poor countries, has agreed to allow eight Indian firms to produce low -cost copies of its most popular HIV drugs. Under this new generic licensing agreement, Indian companies can sell generic versions of Gilead’s drug ‘Viread’, also called ‘Tenofovir’, in India and in 94 low income nations. India tops the list of nations with largest number of HIV infections. A report says that India’s GDP will loose around a percent because of this AIDS epidemic. Many analysts believe that allowing Indian companies to make generic versions of ‘Viread’ will make this drug a lot cheaper, making it more affordable to HIV patients living in poor countries. To read more click here
Blogger News Network is advertiser-supported, and your visits to our advertisers help BNN to meet its expenses. Help keep us afloat! posted by A.K.Siva at 6:02 AM |
Subscribe to BNN and get a daily bulletin of all our news postings. Interested in writing for BNN? Want information on our news service? Contact The Editor Writing for BNN BNN Editorial Policies Previous Posts
|
0 Comments:
Post a Comment
Links to this post:
Create a Link
<< Home